The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases (Q36331229)

13 August 2017

1 reference

title

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases (English)

1 reference

13 August 2017

0 references

Gert Van Assche

0 references

Paul Rutgeerts

series ordinal

object named as

Paul Rutgeerts

0 references

Séverine Vermeire

series ordinal

object named as

Séverine Vermeire

0 references

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Nature Reviews Gastroenterology & Hepatology

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

580-586

1 reference

C-reactive protein reassessed

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Differing acute phase responses in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Update in inflammatory bowel disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Indications for investigation of chronic gastrointestinal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Predicting outcome in severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Useful Markers for Predicting Severity and Monitoring Progression of Acute Pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Acute phase response in patients with uncomplicated and complicated endoscopic retrogradic cholangiopancreaticography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

C-reactive protein and the risk of incident colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

C-reactive protein levels are not associated with increased risk for colorectal cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

Evidence for continuous stimulation of interleukin-6 production in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Evaluation of different laboratory tests and activity indices reflecting the inflammatory activity of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Comparison of serum total sialic acid, C-reactive protein, alpha 1-acid glycoprotein and beta 2-microglobulin in patients with non-malignant bowel diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

C-reactive protein, inflammation, and coronary risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Search for prognostic markers for acute pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Do normal leucocyte count and C-reactive protein on admission to hospital exclude a life-threatening attack of acute pancreatitis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Significance of measurement of high-sensitivity C-reactive protein in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Systemic inflammatory response predicts survival following curative resection of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0359

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0359

1 reference

13 August 2017

1 reference